MICROBIOLOGY • VIROLOGY

Viral Replication Stages — Stages of viral replication and host dependence

Understanding how viruses commandeer host cellular machinery to propagate through a precisely orchestrated replication cycle.

Historical Context & Motivation

The concept of viral replication has its roots in the earliest observations of infectious agents smaller than bacteria. In 1892, Dmitri Ivanovsky demonstrated that the causative agent of tobacco mosaic disease could pass through porcelain filters that retained all known bacteria, inaugurating the study of filterable agents — entities too small to be seen by light microscopy and incapable of independent growth. This discovery posed a fundamental question: how could something so small, lacking its own metabolic machinery, replicate and cause disease? The answer required decades of biochemical and genetic investigation, culminating in a modern understanding of the stepwise process by which viruses exploit host cells to reproduce.

1892
Ivanovsky's Filtration Experiments
Dmitri Ivanovsky showed that the pathogen causing tobacco mosaic disease passed through Chamberland filters, establishing the existence of sub-bacterial infectious agents.
1939
Electron Microscopy of Viruses
The first electron micrographs of tobacco mosaic virus by Helmut Ruska revealed the rod-shaped morphology of viral particles, providing direct visual evidence of virion structure.
1952
Hershey–Chase Experiment
Alfred Hershey and Martha Chase used radiolabeled bacteriophages to demonstrate that DNA, not protein, carries the genetic information injected into host cells — a cornerstone of understanding viral replication.
1970
Discovery of Reverse Transcriptase
Howard Temin and David Baltimore independently discovered reverse transcriptase in retroviruses, challenging the central dogma and revealing a novel replication strategy whereby RNA genomes are converted to DNA.
2003
SARS-CoV and Modern Virology
The emergence of SARS-CoV catalyzed rapid advances in understanding coronavirus replication, including the role of replicase-transcriptase complexes, foreshadowing the global response to SARS-CoV-2.

These milestones collectively underscore a central theme in virology: viruses are obligate intracellular parasites that depend entirely on host cell resources for their propagation. The question driving this lesson is deceptively simple — what are the discrete stages through which a virus transforms a single infection event into the release of hundreds or thousands of progeny virions? Understanding these stages is not merely academic; it provides the mechanistic basis for designing antiviral drugs, vaccines, and diagnostic strategies that target specific vulnerabilities in the replication cycle.

Core Principles of Viral Replication

Before examining the individual stages, it is essential to appreciate four foundational principles that govern every viral replication cycle, regardless of whether the pathogen is a bacteriophage, an enveloped RNA virus, or a complex DNA virus. These principles define the conceptual framework within which the molecular details of attachment, entry, genome replication, assembly, and release all operate.

1

Obligate Host Dependence

Viruses lack ribosomes, ATP-generating systems, and biosynthetic enzymes. They must hijack host machinery — including ribosomes, tRNAs, amino acids, nucleotide pools, and energy currency — for every macromolecular synthesis event.
2

Receptor-Mediated Specificity

Viral tropism — the range of cells a virus can infect — is primarily determined by the interaction between a viral surface protein (the anti-receptor) and a specific host cell receptor molecule.
3

Genome Strategy Dictates Mechanism

The Baltimore classification system organizes viruses into seven classes based on genome type (dsDNA, ssDNA, dsRNA, +ssRNA, −ssRNA, ssRNA-RT, dsDNA-RT). Each class employs a distinct pathway to produce mRNA, which is the universal intermediate for protein synthesis.
4

Self-Assembly and Stoichiometry

Viral structural proteins typically self-assemble into capsids driven by thermodynamically favorable protein–protein interactions. Icosahedral symmetry and helical symmetry are the two dominant architectural motifs, each optimizing the ratio of genome-coding capacity to structural protein requirement.
KEY TAKEAWAY
Think of a virus as a flash drive containing only a set of instructions but no computer. The flash drive is useless until it is plugged into a host machine (the cell) that supplies the processor (ribosomes), power supply (ATP), and raw materials (nucleotides and amino acids). The virus's instructions redirect the host computer to manufacture copies of the flash drive instead of performing its normal tasks. This analogy captures both the obligate parasitism and the information-driven nature of viral replication.

The Viral Replication Cycle — Visual Overview

The generalized viral replication cycle can be divided into six major stages: attachment, penetration (entry), uncoating, replication and transcription, assembly, and release. The following diagram presents these stages as a sequential pathway, illustrating how a single virion interacts with a host cell from initial contact through progeny egress.

The six canonical stages of the viral replication cycle. Stage 1 (Attachment) occurs at the cell surface; stages 2–5 occur inside the host cell (shaded region); stage 6 (Release) returns progeny virions to the extracellular environment.

The diagram above presents a generalized scheme applicable to most animal viruses, though significant variations exist. For example, bacteriophages inject their genome directly through the cell wall without full particle entry, and retroviruses insert an additional reverse transcription step between uncoating and genome replication. Despite these variations, every virus must accomplish the same fundamental objectives: deliver its genome into the host cell, commandeer the host's biosynthetic apparatus, produce progeny genomes and structural proteins, assemble these components into new virions, and exit the cell to initiate new rounds of infection.

Mechanistic Deep Dive — Each Stage in Detail

Stage 1 — Attachment (Adsorption)

The replication cycle begins with attachment (also called adsorption), a process governed by the specific, lock-and-key interaction between a viral surface protein and a host cell receptor. In the case of HIV-1, the gp120 glycoprotein binds the CD4 receptor on T-helper lymphocytes, followed by engagement of a co-receptor (CCR5 or CXCR4). Similarly, influenza virus hemagglutinin (HA) recognizes sialic acid residues on host glycoproteins and glycolipids. The binding affinity and receptor density together determine the efficiency of attachment; this specificity is the primary determinant of viral tropism — that is, which cell types and host species a given virus can infect.

Stage 2 — Penetration (Entry)

Following attachment, the virus must cross the host cell membrane. Three principal mechanisms accomplish this. Direct fusion occurs when viral envelope glycoproteins (such as HIV gp41) undergo conformational changes that insert fusion peptides into the host membrane, merging the viral and cellular lipid bilayers. Receptor-mediated endocytosis engulfs the virion in a clathrin-coated vesicle; acidification of the endosome then triggers conformational changes in viral proteins (as in influenza), releasing the genome into the cytoplasm. In bacteriophages, genome injection occurs through the tail apparatus, with the capsid remaining outside the cell — a mechanism elegantly demonstrated by the Hershey–Chase experiment.

Stage 3 — Uncoating

Once inside the cell, the viral genome must be liberated from its protective protein coat — a process termed uncoating. For non-enveloped viruses such as adenovirus, host cell proteasomes and endosomal pH changes destabilize the capsid, progressively exposing the viral DNA. For enveloped viruses that enter by fusion, the nucleocapsid is released directly into the cytoplasm and may be partially disassembled by host chaperone proteins. In retroviruses, the reverse transcription complex remains associated with viral proteins during reverse transcription, and the DNA product is subsequently imported into the nucleus as part of the pre-integration complex.

Stage 4 — Replication and Transcription

This stage represents the biosynthetic phase and is the most variable across viral families. The Baltimore classification provides the organizing logic: every virus must produce mRNA that host ribosomes can translate. Class I dsDNA viruses (e.g., herpesviruses) can use host RNA polymerase II directly for transcription. Class IV positive-sense ssRNA viruses (e.g., poliovirus, SARS-CoV-2) carry genomes that function immediately as mRNA upon entry, but require a virus-encoded RNA-dependent RNA polymerase (RdRp) to replicate their genomes. Class V negative-sense ssRNA viruses (e.g., Ebola, influenza) must first transcribe their genomes into mRNA using a virion-associated RdRp before any translation can occur. Class VI retroviruses (e.g., HIV) reverse-transcribe their RNA genome into dsDNA, which integrates into the host chromosome and is then transcribed by host machinery.

Stage 5 — Assembly

Newly synthesized viral genomes and structural proteins converge for assembly into progeny virions. Icosahedral capsids self-assemble from multiple copies of capsid protein subunits (capsomeres), often around a scaffolding protein that is later removed or proteolytically cleaved. Helical nucleocapsids, such as those of tobacco mosaic virus, assemble cooperatively as coat protein disks stack along the RNA genome. For enveloped viruses, assembly occurs at cellular membranes: influenza virus acquires its envelope by budding through the plasma membrane, while herpesviruses acquire their primary envelope from the inner nuclear membrane. Packaging signals — specific nucleotide sequences on the viral genome — ensure that viral nucleic acid, rather than host mRNA, is preferentially incorporated into virions.

Stage 6 — Release (Egress)

The final stage returns progeny virions to the extracellular space. Two principal mechanisms accomplish this. Lysis involves rupture of the host cell membrane, releasing a burst of virions and killing the cell; this is typical of non-enveloped viruses and lytic bacteriophages. Budding allows enveloped viruses to exit the cell without immediate destruction, as the virion pushes through a membrane decorated with viral glycoproteins; this can enable persistent or chronic infections because the cell may survive and continue releasing virions over extended periods. Influenza virus neuraminidase cleaves sialic acid from the cell surface, preventing newly budded virions from re-binding to the producer cell — the mechanism targeted by the antiviral drug oseltamivir (Tamiflu).

Genome Strategy and the Baltimore Classification

The Baltimore classification system, devised by Nobel laureate David Baltimore in 1971, organizes all viruses into seven classes based on the relationship between their genome and the production of messenger RNA. Because mRNA is the obligate intermediate for protein synthesis, the pathway a virus uses to produce mRNA defines the most fundamental feature of its replication strategy. The following diagram and table present this classification alongside the host machinery each class exploits.

The Baltimore classification illustrates how seven genome types each reach the same destination — (+) mRNA — which is then translated by host ribosomes into viral proteins. Classes I and II use host polymerases; classes III–V rely on viral RNA-dependent RNA polymerase; class VI uses reverse transcriptase; class VII uses both reverse transcriptase and host RNA polymerase.
Baltimore classification summary with representative examples and host dependence
Baltimore ClassGenome TypeExampleKey Viral EnzymeHost Machinery Used
IdsDNAHerpesvirus, AdenovirusViral DNA polymeraseHost RNA Pol II, ribosomes, splicing machinery
IIssDNAParvovirusHost DNA polymerase converts to dsDNAHost DNA Pol, RNA Pol II, ribosomes
IIIdsRNAReovirus, RotavirusViral RdRp (carried in virion)Ribosomes, tRNAs, amino acids
IV(+) ssRNASARS-CoV-2, PoliovirusViral RdRp (translated from genome)Ribosomes, membrane remodeling, cap-dependent translation
V(−) ssRNAInfluenza, EbolaViral RdRp (carried in virion)Ribosomes, cap-snatching from host mRNA (Influenza)
VIssRNA-RTHIV, HTLVReverse transcriptase, IntegraseHost RNA Pol II, ribosomes, nuclear import machinery
VIIdsDNA-RTHepatitis BReverse transcriptaseHost RNA Pol II, ribosomes, encapsidation signals

Worked Example — Tracing HIV-1 Replication

To consolidate the replication stages, let us trace the complete replication cycle of HIV-1, a Class VI retrovirus. This example demonstrates every canonical stage while highlighting the unique features introduced by reverse transcription and proviral integration.

HIV-1 Replication Cycle — Step by Step
1
Step 1 — AttachmentThe HIV-1 envelope glycoprotein gp120 binds the CD4 receptor on the surface of a T-helper cell. This initial binding induces a conformational change in gp120 that exposes the V3 loop, which then engages a co-receptor — either CCR5 (in early infection, macrophage-tropic strains) or CXCR4 (in late infection, T-cell-tropic strains).
Virus attached via gp120–CD4–co-receptor ternary complex.
2
Step 2 — Penetration (Membrane Fusion)Co-receptor engagement triggers a conformational change in gp41, the transmembrane glycoprotein. The hydrophobic fusion peptide of gp41 inserts into the host cell membrane, bringing viral and host membranes into close apposition. Formation of a six-helix bundle structure drives membrane fusion, releasing the viral core into the cytoplasm. Enfuvirtide, an FDA-approved peptide inhibitor, blocks this step by preventing six-helix bundle formation.
Viral core (capsid + RNA genome + RT + integrase) delivered to cytoplasm.
3
Step 3 — Uncoating and Reverse TranscriptionWithin the cytoplasm, the conical capsid partially disassembles. The virion-associated enzyme reverse transcriptase (RT) converts the two copies of (+) ssRNA genome into a single copy of double-stranded DNA (dsDNA), also known as the provirus. RT performs three enzymatic activities: RNA-dependent DNA polymerization, RNase H degradation of the RNA template, and DNA-dependent DNA polymerization. This step is targeted by nucleoside RT inhibitors (NRTIs, e.g., tenofovir) and non-nucleoside RT inhibitors (NNRTIs, e.g., efavirenz).
Linear dsDNA provirus formed within the pre-integration complex.
4
Step 4 — Integration and Transcription (Genome Replication)The pre-integration complex is transported into the nucleus, where the viral enzyme integrase catalyzes insertion of the proviral DNA into the host chromosome. The integrated provirus is transcribed by host RNA polymerase II, producing both full-length genomic RNA (for packaging) and spliced mRNAs encoding regulatory (Tat, Rev, Nef) and structural (Gag, Pol, Env) proteins. Integrase strand-transfer inhibitors (INSTIs, e.g., dolutegravir) block this step.
Proviral DNA integrated; viral mRNAs and full-length genomic RNA produced.
5
Step 5 — AssemblyThe Gag polyprotein traffics to the inner leaflet of the plasma membrane, where it oligomerizes and recruits two copies of full-length genomic RNA via the psi (Ψ) packaging signal. Env glycoproteins (gp120/gp41), synthesized in the ER and processed through the Golgi, are displayed on the cell surface at assembly sites.
Immature virion assembled at the plasma membrane.
6
Step 6 — Release and MaturationThe immature virion buds from the plasma membrane, acquiring its lipid envelope studded with Env trimers. Simultaneously or shortly after budding, the viral protease cleaves the Gag and Gag-Pol polyproteins into mature structural and enzymatic subunits (MA, CA, NC, RT, IN, PR). This maturation step transforms the non-infectious immature particle into an infectious mature virion. Protease inhibitors (e.g., darunavir) block this final maturation, producing non-infectious particles.
Mature, infectious HIV-1 virion released — ready to infect new CD4⁺ cells.
💊 Clinical Relevance
Each enzymatic step unique to HIV (reverse transcription, integration, protease-mediated maturation) represents a target for antiretroviral therapy. Modern combination antiretroviral therapy (cART) typically uses drugs from at least two different mechanistic classes, suppressing viral replication to undetectable levels and dramatically reducing the probability of resistance evolution.

Lytic vs. Lysogenic Cycles — Comparative Analysis

Not all viral infections proceed immediately through the full replication cycle. Many viruses can adopt alternative replicative strategies depending on host and environmental conditions. The distinction between the lytic cycle and the lysogenic cycle (or its animal virus equivalents, latency and persistent infection) is fundamental to understanding viral pathogenesis, epidemiology, and therapy.

Comparison of lytic and lysogenic (latent) replication strategies
FeatureLytic CycleLysogenic / Latent Cycle
Outcome for host cellCell lysis and death; release of progeny virionsCell survival; viral genome maintained within host
Viral genome stateActively replicated and expressedIntegrated (prophage/provirus) or maintained as episome; gene expression silenced or minimal
Progeny productionImmediate; burst of virions per cell (10–10,000+)None until induction/reactivation triggers lytic switch
ExamplesT4 phage (obligate lytic), Influenza Aλ phage (temperate), HSV-1 (neuronal latency), HIV-1 (proviral latency in resting CD4⁺ T cells)
Trigger for transitionN/A (obligate lytic) or reactivation stimuliUV damage, immune suppression, stress hormones, or depletion of repressor proteins
Clinical significanceAcute, often symptomatic disease; short-lived infection if immune response is effectiveChronic or latent infection; potential for reactivation disease (e.g., shingles from VZV); reservoir for HIV cure challenges
KEY TAKEAWAY
The lytic–lysogenic decision can be understood through an analogy to industrial espionage. In the lytic strategy, the spy enters the factory, immediately takes over the assembly lines, mass-produces counterfeit goods, and then destroys the factory upon departure. In the lysogenic strategy, the spy quietly inserts herself into the company's organizational chart, is duplicated every time the company expands, and waits dormant for an opportune moment to activate and seize control. The lysogenic strategy confers an evolutionary advantage by enabling the virus to persist within a host population even when conditions are unfavorable for active replication.

Connections to Advanced Virology

The six-stage replication model presented here provides the essential scaffold, but advanced virology reveals layers of complexity that expand and refine this framework. This section briefly introduces several frontiers that build directly on the replication concepts covered above.

Connecting foundational replication concepts to advanced virology topics
Foundational Concept (This Lesson)Advanced ExtensionSignificance
Receptor-mediated attachmentViral entry and membrane biology — endosomal trafficking, pH-dependent fusion, multivalent bindingDesign of entry inhibitors and neutralizing antibody therapies
RdRp-mediated genome replicationViral evolution and quasispecies theory — error-prone replication produces diverse mutant swarmsExplains drug resistance, immune evasion, and cross-species transmission
Host ribosome dependenceHost shutoff mechanisms — viruses degrade or sequester host mRNA to monopolize ribosomesUnderstanding cytopathic effects and viral pathogenesis
Capsid self-assemblyStructural virology and capsid-targeted antivirals — cryo-EM structures reveal druggable assembly intermediatesLenacapavir (HIV capsid inhibitor) represents a new drug class
Lysogeny and proviral latencyLatent reservoir biology and cure strategies — 'shock and kill' vs. 'block and lock' approaches for HIVCentral obstacle to eradication of HIV and other persistent viruses

Additionally, the study of innate immune sensing of replication intermediates has become a major focus in modern virology. Host pattern-recognition receptors (PRRs) such as RIG-I and cGAS detect viral nucleic acids produced during replication, triggering interferon responses. Viruses, in turn, encode antagonists that block these sensors at virtually every step. Understanding viral replication is therefore inseparable from understanding the innate immune response — a topic that sits at the intersection of virology and immunology and that drives the design of next-generation vaccines and immunotherapeutics.

Practice Problems

PROBLEM 1CONCEPTUAL
Explain why viruses are considered obligate intracellular parasites. Specifically, identify at least three categories of cellular resources that viruses cannot provide for themselves and must co-opt from the host.
PROBLEM 2BASIC CALCULATION
A bacteriophage has a burst size of 200 virions per infected cell and an eclipse period (time from infection to first intracellular virion assembly) of 15 minutes. If a single phage infects a bacterium and the latent period (time to lysis) is 25 minutes, how many free phage particles are present in the culture 75 minutes after the initial infection, assuming every released phage immediately infects a new host cell and all host cells are susceptible? (Ignore any time for attachment/penetration — assume instantaneous reinfection.)
PROBLEM 3INTERMEDIATE
A researcher discovers a novel RNA virus whose purified genomic RNA, when transfected directly into permissive cells, does not produce infectious progeny. However, when intact virions are used to infect the same cells, productive infection occurs. Based on the Baltimore classification, which classes of RNA viruses would be consistent with this observation, and why?
PROBLEM 4APPLIED
Oseltamivir (Tamiflu) inhibits influenza virus neuraminidase. Which specific stage of the influenza replication cycle is directly blocked by this drug? How does inhibition of neuraminidase affect the spread of infection, and why is the drug most effective when administered within 48 hours of symptom onset?
PROBLEM 5CRITICAL THINKING
HIV-1 integrates its proviral DNA into the host chromosome, establishing a stable latent reservoir in resting memory CD4⁺ T cells. Propose and evaluate two distinct therapeutic strategies for eliminating this latent reservoir, explaining how each strategy relates to specific stages of the viral replication cycle. Discuss the scientific and practical challenges associated with each approach.

Lesson Summary

Viral replication proceeds through six canonical stages: attachment (receptor-mediated binding), penetration (entry by fusion, endocytosis, or injection), uncoating (capsid removal and genome exposure), replication and transcription (the biosynthetic phase, whose mechanism is determined by Baltimore classification), assembly (self-assembly of capsids with genome packaging), and release (via lysis or budding). Every stage reflects the virus's absolute dependence on host cellular machinery — from ribosomes and energy supplies to membrane lipids and nuclear import systems.

The lytic–lysogenic decision adds a strategic dimension: some viruses replicate immediately and destroy the host cell, while others integrate or persist silently, reactivating when conditions favor productive replication. The seven Baltimore classes define the specific enzymatic pathways each genome type uses to reach the universal intermediate — mRNA — and each pathway creates unique vulnerabilities exploitable by antiviral drugs. Understanding these replication stages is the foundation for rational drug design, vaccine development, and comprehension of viral pathogenesis across all domains of virology.

Varsity Tutors • Microbiology • Viral Replication Stages